4Kang YK,Kang WK,Shin DB,et al.Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma[J].Cancer chemother Pharmacol,2008,62(1):77-84.
5Boone J,van HR,Offerhaus GJ,et al.Targets for molecular therapy in esophageal squamous cell carcinoma:an immunohistochemical analysis[J].Dis Esophagus,2009,22(6):496-504.
6Mayté,Lima Pérez.5th Nimotuzumab Global Scientific Meeting[J].2009(Havana).
2Conroy T, Etienne P L, Adenis A, et al. Vinorelbine and cisplatin in metastatic aquamous cell carcinoma of the oesophagus:response, toxicity, quality of life and survival [J]. Ann Oncol,2002, 13(5): 721-729.
3Miller A B, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment[J]. Cancer, 1981,47(1): 207-214.
5Lisa B, Giulino MD, James B, et al. Treatment with rituximab in benign and malignant hematologic disorders in children[J]. The Journal of Pediatrics,2007,4:399-344.
6Jonker DJ, O'Callaghan CJ, Karapetis CS, et al. Cetuximab for the trealment of colorectal cancer[J]. N Engl J Med,2007,357(20):2040-2048.
7Crombet T, Ramos T, Rak J,et al. Anfipmfiferative,antianglogenic and proapoptotic activity of A Humanized anti-EGFR antibody[J]. Int J Cancer,2002,101(6):567-575.
9Bebb G,Smith C,Rorke S.Phase Ⅰ clinical trial of the anti-EG-FR monoclonal antibody nimotuzumab with concurrent external thoracic radiotherapy in Canadian patients diagnosed with stage Ⅱ b,Ⅲ or Ⅳ non-small cell lung cancer unsuitable for radical therapy.Cancer Chemotherapy and Pharmacol,2011,67 (4):837-845.
10Soriano J,Batista N,Lima M.Phase Ⅰ clinical study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody (Nimotuzumab) in combination with chemotherapy in patients with locally-advanced breast cancer.Preliminary resuits.Eur J Cancer Supplements,2007,5 (4):116.
